The B2B Podcast Index
If Prices Could Talk

Pricing with confidence in a fear-driven market with Scott Leick, RhythmScience

If Prices Could Talk · 2025-04-23 · 53 min

Episode notes

In this episode, Tracy sits down with Scott Leick, SVP of Finance & Analytics at RhythmScience, and Patrick McCullough, Partner at Holden Advisors, to discuss pricing, analytics, negotiations, and new product launches. We discuss: ​How to use analytics to replace gut instinct in pricing decisions ​Lessons from the drug-eluting stent “race to the bottom” on price ​How to price new tech when the market is uncertain ​The impact of private equity ownership on purchasing power ​How to align commercial teams when sellers are under pressure to deliver About Scott Scott Leick is the SVP of Finance and Marketing at RhythmScience. He has almost 25 years of experience in pricing at companies from the Fortune 50 to Series A SaaS startups, including executive roles at Medtronic, C.H. Robinson, and Acutus Medical. Learn more about RhythmScience: Learn more about Holden Advisors:

More from If Prices Could Talk

All episodes →
Listen to this episodeAll If Prices Could Talk episodes →